Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015)
Yang Chen, Ziyi Zhong, Ying X. Gue, Maciej Banach, Garry McDowell, Dimitri P. Mikhailidis, Peter P. Tóth, Peter E. Penson, Tomasz Tomasik, Adam Windak, Marek Gierlotka, Tadeusz Osadnik, Agnieszka Kuras, Marcin Miga, Jacek Jerzy Jozwiak, Gregory Y.H. Lip, B. Al-Shaer, W. Andrusewicz, M. Andrzejczuk-Rosa, E. Anusz-Gaszewska, A. Bagińska, P. Balawajder, G. Bańka, E. Barańska-Skubisz, B. Barbara Przyczyna, S. Bartkowiak, J. Bartodziej, M. Bartosiewicz, M. Basałyga, A. Batyra, A. Bąk, M. Bednarz, K. Bejnar, W. Bernacki, M. Betiuk-Kwiatkowska, S. Biegaj, M. Bień, W. Bilski, M. Biłogan, G. Biruta-Pawłowska, A. Biskup, B. Błaszczyk, H. Błaszczyk, T. BłońskaJankowska, B. Bogacka-Gancarczyk, M. Bojanowska, E. Bonda, J. Borowik-Skwarek, J. Borowska, J. Bruckner, J. Brzostek, M. Brzuchacz, M. Budzyńska, I. Bulzacka-Fugiel, J. Bulzak, K. Bunikowski, A. Cebulska, T. Celka, E. Cempel-Nowak, W. Chechliński, A. Chludzińska, D. Chmiel, M. Chmielewska, M. Cichy, A. Ciemięga, A. Ciepluch, I. Cieszyńska, B. Czajka, B. Czapla, M. Czerner, B. Czerwińska, W. Czuryszkiewicz, E. Daleka, Z. Dawid, M. Dąbrowska, R. Dąbrowska, D. Dąbrowski, M. Dąbrowski, K. Demczyszyn, A. Dębowska-Serwińska, J. Dmochowski, J. Dobrzecka-Kiwior, E. Dolanowska, H. Dolanowski, P. Dołek, M. Domagała, H. Domański, A. Doszel, D. Duda, M. Dudkowska, B. Dudziuk, P. Dybciak, M. Dymanowski, L. Dziadzio-Bolek, M. Eicke, H. El-Hassan, A. Eremus, M. Fąferek-Muller, E. Figura-Roguska, I. Fijałkowska-Kaczmarek
Abstract
Background: Insulin resistance (IR) is an important risk factor for multiple chronic diseases, increasing mortality and reducing life expectancy. The associations between emerging surrogates for IR, triglyceride-glucose index (TyG) and TyG-related indicators, with all-cause mortality and life expectancy in middle-aged and older patients in primary care are unclear. Methods: This study originated from the Polish primary care cohort LIPIDOGRAM2015, including patients aged ≥45 years. Baseline fasting triglycerides and fasting glucose were used to derive TyG. Other TyG-related indicators included TyG-adjusted body mass index (TyG-BMI), TyG-adjusted waist circumference (TyG-WC), TyG-adjusted waist-to-hip, and TyG-adjusted waist-to-height. In this longitudinal analysis, we assessed associations between TyG-related indicators with total all-cause mortality, premature (age at death ≤75 years) all-cause mortality and years of life lost (YLL). Findings: We included 10,688 patients (mean age 61.8 ± 9.3 years; 63.5% female). Cumulative total and premature all-cause mortality were 7.2% and 4.6%, respectively, during 5.7 years (IQR 5.6-5.7) of follow-up. Lowest (Q1) and highest quartile (Q4) of TyG-BMI and TyG-WC were associated with total all-cause mortality (second quartile [Q2]: reference; TyG-BMI: Q1: aHR 1.33, 95% CI 1.07-1.65, Q4: aHR 1.28, 95% CI 1.03-1.58; TyG-WC: Q1: aHR 1.44, 95% CI 1.14-1.82, Q4: aHR 1.29, 95% CI 1.04-1.59), similar results for premature all-cause mortality. Within age 45-80 years, compared with Q2 and third quartile, YLL were 4.49 and 5.46 years for TyG-BMI Q1 and Q4, respectively, 3.24 and 5.31 years for TyG-WC Q1 and Q4, respectively. Interpretation: TyG-BMI and TyG-WC demonstrated a U-shaped association with total and premature all-cause mortality. Low and high levels of TyG-BMI and TyG-WC were associated with reduced life expectancy. Despite the relatively short follow-up period, significant associations were still observed, but longer follow-up studies are required to further explore these relationships. Funding: Polish Lipid Association, College of Family Physician in Poland, Valeant in Poland.